<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02370628</url>
  </required_header>
  <id_info>
    <org_study_id>CE14.334</org_study_id>
    <nct_id>NCT02370628</nct_id>
  </id_info>
  <brief_title>Vertebroplasty In The Treatment Of Acute Fracture Trial - The VITTA Trial</brief_title>
  <acronym>VITTA</acronym>
  <official_title>Vertebroplasty In The Treatment Of Acute Fracture Trial (The VITTA Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The VITTA trial is a randomized, controlled, single-blinded, cross-over trial comparing
      percutaneous vertebroplasty with facet block in patients with acute (&lt;1month) and painful
      vertebral compression fractures.

      The treatment offered for vertebral compression fractures (VCFs) in the interventional arm of
      the trial is vertebroplasty, which will be performed in accordance with the standardized
      protocol of the Canadian Association of Radiologists. Patients in the control arm will
      receive facet block, where a long-acting local anesthetic agent and corticosteroids are
      injected in the spinal articular facets at the affected level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vertebroplasty is a procedure used to stabilize broken vertebrae, the bones that form the
      spine. This study will evaluate the effectiveness of vertebroplasty for the treatment of
      acute vertebral fractures.

      The VITTA trial is a randomized, controlled, single-blinded, cross-over trial comparing
      percutaneous vertebroplasty with facet block in patients with acute (&lt;1 month) and painful
      vertebral compression fractures.

      Vertebral compression fractures (VCFs) frequently result in debilitating pain, impaired
      functional status and bad quality of life. Percutaneous vertebroplasty (PV) is a treatment
      for VCFs originally developed in France in the late 1980s and first performed in America in
      the mid-1990s. The procedure involves percutaneous application of bone cement
      (polymethylmethacrylate) into collapsed vertebrae.

      VCFs are a significant public health problem with approximately 750,000 new fractures
      occurring in the United States each year, a number that is projected to rise as the
      population ages. In fact, one quarter of adults over the age of 50 will suffer at least one
      VCF in their lifetime. VCFs cause short term and occasionally long-term pain and disability,
      and although not immediately life threatening, they are associated with long term mortality.
      Before the advent of PV, the treatment for VCFs was limited to medical therapy- addressing
      the pain associated with the fracture but not the fracture itself thus making VCFs
      practically the only skeletal fracture not treated with orthopedic surgery. Since the
      introduction of vertebroplasty, over 800 papers, technical notes, and reviews that address
      this technique have been published with the overwhelming majority reporting significant pain
      relief and advocating the adoption of the procedure into common practice. Unfortunately, most
      of these studies had low evidence level and poor scientific design until randomized clinical
      trials were published in 2009.

      Vertebroplasty for refractory back pain (after a period of conservative management of 1
      month) constituted the main indication in the overwhelming majority of studies published so
      far. Although those studies have largely suggested that it does not offer significant
      improvement in pain or functional status relative to medical therapy or infusion of local
      anesthesia after this acute phase, the data remains inconclusive and of poor scientific
      quality. The present study proposes a different rationale: the benefits of vertebroplasty may
      be occurring in the acute phase (before 1 month) by providing immediate pain relief to the
      patient, hence allowing early mobilization and preventing medical complications associated
      with bed rest. In other terms, vertebroplasty may be a first line, acute phase treatment. If
      the investigators hypothesis holds true, an adequately powered clinical trial may provide
      sufficient evidence to change the medical indications for vertebroplasty.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Achieving a score of 75 or higher on the Barthel Index functional evaluation score</measure>
    <time_frame>30 days after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of cross-over to the alternative treatment</measure>
    <time_frame>15 days after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of pain as measured by the visual analogue pain scale</measure>
    <time_frame>at 15 days and 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients located at home</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">495</enrollment>
  <condition>Vertebral Compression Fractures</condition>
  <arm_group>
    <arm_group_label>Percutaneous vertebroplasty (PV)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The procedure involves percutaneous application of bone cement (polymethylmethacrylate) into collapsed vertebrae.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Facet block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>injection of anti-inflammatory and analgesic drugs</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous vertebroplasty</intervention_name>
    <description>The procedure involves percutaneous application of bone cement (polymethylmethacrylate) into collapsed vertebrae, and has been used for treatment of patients with osteoporosis who have severe or prolonged pain following vertebral compression fracture, as well as those with painful, aggressive hemangiomas and osteolytic neoplasms.
In our trial, vertebroplasty shall be performed in two steps:
Step 1: facet block
Step 2: cement infusion
Therefore, patients in both arms will undergo Step 1 since our control intervention serves as a routine first part of our active intervention.</description>
    <arm_group_label>Percutaneous vertebroplasty (PV)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Facet block</intervention_name>
    <description>A long-acting local anesthetic agent and corticosteroids are injected in the spinal articular facets at the affected level.
All patients will undergo facet block since it serves as a routine first part to percutaneous vertebroplasty.</description>
    <arm_group_label>Percutaneous vertebroplasty (PV)</arm_group_label>
    <arm_group_label>Facet block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Presence of:

          -  at least one and at most two acute VCF (&lt; 6 weeks) at levels caudate to T4, confirmed
             with physical examination and radiographic imaging

          -  if timing of the fracture is unclear, the following criteria are required for
             inclusion in the trial

               1. an MRI scan showing edema at the fracture level(s) or

               2. a bone scan showing increased uptake

          -  Physical examination showing axial back pain likely secondary to the VCF with
             restricted mobilization (score not maximum on any one of the following Barthel's Index
             items: transfer, mobility, bathing, dressing, stairs and toilet use)

          -  French or English speaking patient willing to return for follow-up or capable of
             following up with phone interviews if needed

        Exclusion Criteria:

          -  Recent (&lt;30 days) major surgery causing debilitating pain

          -  Coagulopathy or thrombocytopenia precluding interventional treatment

          -  Inability to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean Raymond, MD</last_name>
    <phone>514-890-8000</phone>
    <phone_ext>27235</phone_ext>
    <email>jean.raymond@umontreal.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Suzanne Nolet</last_name>
    <phone>514-890-8000</phone>
    <phone_ext>26359</phone_ext>
    <email>Suzanne.Nolet@crchum.qc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre hospitalier de l'Université de Montréal (CHUM)</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Raymond, MD</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>27235</phone_ext>
      <email>jean.raymond@umontreal.ca</email>
    </contact>
    <contact_backup>
      <last_name>Suzanne Nolet</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>26359</phone_ext>
      <email>Suzanne.Nolet@crchum.qc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel Roy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alain Weill, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Bourgoin P, Weill A, Tampieri D. CAR Standard for Performance of the Percutaneous Vertebroplasty. Can Assoc Radiol. 2002;(March).</citation>
  </reference>
  <reference>
    <citation>Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, Ralston SH, Jarvik JG. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009 Aug 6;361(6):569-79. doi: 10.1056/NEJMoa0900563. Erratum in: N Engl J Med. 2012 Mar 8;366(10):970.</citation>
    <PMID>19657122</PMID>
  </reference>
  <reference>
    <citation>Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009 Aug 6;361(6):557-68. doi: 10.1056/NEJMoa0900429.</citation>
    <PMID>19657121</PMID>
  </reference>
  <reference>
    <citation>Comstock BA, Sitlani CM, Jarvik JG, Heagerty PJ, Turner JA, Kallmes DF. Investigational vertebroplasty safety and efficacy trial (INVEST): patient-reported outcomes through 1 year. Radiology. 2013 Oct;269(1):224-31. doi: 10.1148/radiol.13120821. Epub 2013 May 21.</citation>
    <PMID>23696683</PMID>
  </reference>
  <reference>
    <citation>Voormolen MH, Mali WP, Lohle PN, Fransen H, Lampmann LE, van der Graaf Y, Juttmann JR, Jansssens X, Verhaar HJ. Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. AJNR Am J Neuroradiol. 2007 Mar;28(3):555-60.</citation>
    <PMID>17353335</PMID>
  </reference>
  <reference>
    <citation>Do HM, Kim BS, Marcellus ML, Curtis L, Marks MP. Prospective analysis of clinical outcomes after percutaneous vertebroplasty for painful osteoporotic vertebral body fractures. AJNR Am J Neuroradiol. 2005 Aug;26(7):1623-8.</citation>
    <PMID>16091504</PMID>
  </reference>
  <reference>
    <citation>Deramond H, Darrason R GP. Percutaneous vertebroplasty with acrylic cement in the treatment of aggressive spinal angiomas. Rachis. 1989;1(2):143-53.</citation>
  </reference>
  <reference>
    <citation>Jensen ME, Evans AJ, Mathis JM, Kallmes DF, Cloft HJ, Dion JE. Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol. 1997 Nov-Dec;18(10):1897-904.</citation>
    <PMID>9403451</PMID>
  </reference>
  <reference>
    <citation>Deramond H, Depriester C, Galibert P, Le Gars D. Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results. Radiol Clin North Am. 1998 May;36(3):533-46.</citation>
    <PMID>9597071</PMID>
  </reference>
  <reference>
    <citation>Gangi A, Guth S, Imbert JP, Marin H, Dietemann JL. Percutaneous vertebroplasty: indications, technique, and results. Radiographics. 2003 Mar-Apr;23(2):e10.</citation>
    <PMID>12889460</PMID>
  </reference>
  <reference>
    <citation>Gu YF, Li YD, Wu CG, Sun ZK, He CJ. Safety and efficacy of percutaneous vertebroplasty and interventional tumor removal for metastatic spinal tumors and malignant vertebral compression fractures. AJR Am J Roentgenol. 2014 Mar;202(3):W298-305. doi: 10.2214/AJR.12.10497.</citation>
    <PMID>24555629</PMID>
  </reference>
  <reference>
    <citation>Chen G, Luo ZP, Zhang H, Nalajala B, Yang H. Percutaneous kyphoplasty in the treatment of painful osteoblastic metastatic spinal lesions. J Clin Neurosci. 2013 Jul;20(7):948-50. doi: 10.1016/j.jocn.2012.08.010. Epub 2013 May 3.</citation>
    <PMID>23647710</PMID>
  </reference>
  <reference>
    <citation>Pereira LP, Clarençon F, Cormier E, Rose M, Jean B, Le Jean L, Chiras J. Safety and effectiveness of percutaneous sacroplasty: a single-centre experience in 58 consecutive patients with tumours or osteoporotic insufficient fractures treated under fluoroscopic guidance. Eur Radiol. 2013 Oct;23(10):2764-72. doi: 10.1007/s00330-013-2881-3. Epub 2013 May 21.</citation>
    <PMID>23689309</PMID>
  </reference>
  <reference>
    <citation>Weill A, Chiras J, Simon JM, Rose M, Sola-Martinez T, Enkaoua E. Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology. 1996 Apr;199(1):241-7.</citation>
    <PMID>8633152</PMID>
  </reference>
  <reference>
    <citation>Chiras J, Depriester C, Weill A, Sola-Martinez MT, Deramond H. [Percutaneous vertebral surgery. Technics and indications]. J Neuroradiol. 1997 Jun;24(1):45-59. French.</citation>
    <PMID>9303944</PMID>
  </reference>
  <reference>
    <citation>Ruiz Santiago F, Santiago Chinchilla A, Guzmán Álvarez L, Pérez Abela AL, Castellano García Mdel M, Pajares López M. Comparative review of vertebroplasty and kyphoplasty. World J Radiol. 2014 Jun 28;6(6):329-43. doi: 10.4329/wjr.v6.i6.329. Review.</citation>
    <PMID>24976934</PMID>
  </reference>
  <reference>
    <citation>Yimin Y, Zhiwei R, Wei M, Jha R. Current status of percutaneous vertebroplasty and percutaneous kyphoplasty--a review. Med Sci Monit. 2013 Oct 7;19:826-36. doi: 10.12659/MSM.889479. Review.</citation>
    <PMID>24097261</PMID>
  </reference>
  <reference>
    <citation>Liu J, Li X, Tang D, Cui X, Li X, Yao M, Yu P, Qian X, Wang Y, Jiang H. Comparing pain reduction following vertebroplasty and conservative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials. Pain Physician. 2013 Sep-Oct;16(5):455-64.</citation>
    <PMID>24077192</PMID>
  </reference>
  <reference>
    <citation>Fotiadou A, Wojcik A, Shaju A. Management of low back pain with facet joint injections and nerve root blocks under computed tomography guidance. A prospective study. Skeletal Radiol. 2012 Sep;41(9):1081-5. doi: 10.1007/s00256-011-1353-6. Epub 2012 Jan 10.</citation>
    <PMID>22230900</PMID>
  </reference>
  <reference>
    <citation>Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Fellows B. Complications of fluoroscopically directed facet joint nerve blocks: a prospective evaluation of 7,500 episodes with 43,000 nerve blocks. Pain Physician. 2012 Mar-Apr;15(2):E143-50.</citation>
    <PMID>22430660</PMID>
  </reference>
  <reference>
    <citation>Melton LJ 3rd. Epidemiology of spinal osteoporosis. Spine (Phila Pa 1976). 1997 Dec 15;22(24 Suppl):2S-11S. Review.</citation>
    <PMID>9431638</PMID>
  </reference>
  <reference>
    <citation>Jones G, White C, Nguyen T, Sambrook PN, Kelly PJ, Eisman JA. Prevalent vertebral deformities: relationship to bone mineral density and spinal osteophytosis in elderly men and women. Osteoporos Int. 1996;6(3):233-9.</citation>
    <PMID>8783298</PMID>
  </reference>
  <reference>
    <citation>Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009 Feb 4;301(5):513-21. doi: 10.1001/jama.2009.50.</citation>
    <PMID>19190316</PMID>
  </reference>
  <reference>
    <citation>Rousing R, Andersen MO, Jespersen SM, Thomsen K, Lauritsen J. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study. Spine (Phila Pa 1976). 2009 Jun 1;34(13):1349-54. doi: 10.1097/BRS.0b013e3181a4e628.</citation>
    <PMID>19478654</PMID>
  </reference>
  <reference>
    <citation>Diamond TH, Bryant C, Browne L, Clark WA. Clinical outcomes after acute osteoporotic vertebral fractures: a 2-year non-randomised trial comparing percutaneous vertebroplasty with conservative therapy. Med J Aust. 2006 Feb 6;184(3):113-7.</citation>
    <PMID>16460295</PMID>
  </reference>
  <reference>
    <citation>Alvarez L, Alcaraz M, Pérez-Higueras A, Granizo JJ, de Miguel I, Rossi RE, Quiñones D. Percutaneous vertebroplasty: functional improvement in patients with osteoporotic compression fractures. Spine (Phila Pa 1976). 2006 May 1;31(10):1113-8.</citation>
    <PMID>16648745</PMID>
  </reference>
  <reference>
    <citation>Whitley E, Ball J. Statistics review 4: sample size calculations. Crit Care. 2002 Aug;6(4):335-41. Epub 2002 May 10. Review.</citation>
    <PMID>12225610</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2015</study_first_posted>
  <last_update_submitted>August 2, 2017</last_update_submitted>
  <last_update_submitted_qc>August 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>percutaneous vertebroplasty</keyword>
  <keyword>facet block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Fractures, Compression</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polymethyl Methacrylate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

